clinical trial · NCT05080764
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
Acne Vulgaris1h Incubation Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)1h Incubation Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)3h Incubation Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)3h Incubation Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)
brief summary
The aim of this study is to test the safety and efficacy of photodynamic therapy (PDT) for the medication Ameluz® performed with the PDT-lamp BF-RhodoLED® in comparison to the respective placebo treatment for moderate to severe Acne vulgaris.
started
Dec 10, 2021
primary completion
Aug 22, 2025
completion
Jan 1, 2026
last updated
Dec 22, 2025
official title
A Randomized, Double Blind, Vehicle-controlled, Multicenter Phase II Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris in Adults With Photodynamic Therapy (PDT)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol